Related Experiment Video
Updated: Jan 1, 2026
11:07
Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
8.3K
A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure
Tomoaki Muramatsu1, Yasuhito Funahashi1, Akiyuki Yamamoto1
1Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nagoya Journal of Medical Science
|December 19, 2019
Abstract:
Currently, the early introduction of new antiandrogens is popular for castration-resistant prostate cancer (CRPC). However, adverse events can be severe and their costs are high. Here, we present a patient with CRPC in whom flutamide controlled disease progression for 10 years. This case report shows that conventional alternative antiandrogens are cost effective and are still an important option for the treatment for CRPC.
